Midday movers: Diamondback Energy rises, Arm goes parabolic Feb 12, 2024 11:21AM
CymaBay Therapeutics to Present at Upcoming Investor Conferences Aug 30, 2021 08:00AM
CymaBay Therapeutics to Present at Upcoming Investor Conferences Sep 3, 2020 04:05PM
CymaBay Therapeutic (CBAY) PT Raised to $9 at Citi on Increased Probability of Seladelpar for PBC Approval Aug 25, 2020 07:07AM
Pre-Open Movers 11/25: (SRNE) (MDCO) (TIF) Higher (CBAY) (UBER) (PRU) Lower (more...) Nov 25, 2019 09:30AM


Sep 3, 2019 08:00AM CymaBay Therapeutics to Present at Upcoming Investor Conferences in September
Jun 13, 2019 06:24AM CymaBay Therapeutic (CBAY) PT Lowered to $12 at Citi
May 14, 2019 01:58AM Citi Starts CymaBay Therapeutic (CBAY) at Buy
Mar 11, 2019 12:05PM CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 6, 2019 08:04AM CymaBay Therapeutics (CBAY) Prices 8M Common Stock Offering at $12.50/Share
Mar 6, 2019 08:00AM CymaBay Announces Pricing of Public Offering of Common Stock
Mar 5, 2019 04:04PM CymaBay Therapeutics (CBAY) to Offer Common Stock
Mar 5, 2019 04:01PM CymaBay Announces Proposed Public Offering of Common Stock
Aug 14, 2018 08:00AM CymaBay Therapeutics to Participate in Upcoming Investor Conferences in August and September
May 15, 2018 10:14AM Omega's 13F Shows Increase in Ocwen (OCN), Synchrony (SYF), United (UAL), Exits Zynga (ZNGA) (More...)
Oct 31, 2017 08:10AM CymaBay Therapeutics (CBAY) Names Sujal Shah as President and CEO
Oct 31, 2017 08:00AM CymaBay Announces the Appointment of Sujal Shah as President and Chief Executive Officer
Mar 29, 2017 08:02AM CymaBay Therapeutics (CBAY) CEO Harold Van Wart to Retire
Mar 29, 2017 08:00AM CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.